The vaccine targets tumour neoantigens to activate an anti-tumour immune response. It's a custom-built solution for each patient to prevent cancer recurrence.
Collection
[
|
...
]
The vaccine targets tumour neoantigens to activate an anti-tumour immune response. It's a custom-built solution for each patient to prevent cancer recurrence.